Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) rose 76.5% during trading on Friday . The company traded as high as C$0.16 and last traded at C$0.15. Approximately 3,992,349 shares traded hands during mid-day trading, an increase of 1,549% from the average daily volume of 242,055 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Performance
The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The stock has a 50 day simple moving average of C$0.10 and a 200 day simple moving average of C$0.13. The company has a market capitalization of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- 3 Warren Buffett Stocks to Buy Now
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Are Penny Stocks a Good Fit for Your Portfolio?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Profit From Value Investing
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
